Protagonist Therapeutics, Inc. (PTGX)

Protagonist Therapeutics Revenue

Protagonist Therapeutics had revenue of $28.32M in the quarter ending March 31, 2025, a decrease of -88.89%. This brings the company's revenue in the last twelve months to $207.80M, down -34.02% year-over-year. In the year 2024, Protagonist Therapeutics had annual revenue of $434.43M with 624.06% growth.

• Revenue (ttm): $207.80M
• Revenue Growth: -34.02%
• P/S Ratio: 16.09
• Revenue / Employee: $1,649,214
• Employees: 126
• Market Cap: 3.34B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	434.43M	374.43M	624.06%
Dec 31, 2023	60.00M	33.42M	125.73%
Dec 31, 2022	26.58M	-776.00K	-2.84%
Dec 31, 2021	27.36M	-1.27M	-4.44%
Dec 31, 2020	28.63M	28.40M	12,293.07%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.